Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Johnson

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|February 21, 2007
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trialGunjan Y Gandhi, Gregory A Nuttall, Martin D Abel, et al.
Journal of Primary Care & Community Health|April 3, 2026
Health Care Use and Outcomes Among Participants Enrolled in the Mayo Clinic Primary Care House Call Program: A Case-Control StudyPaul Y Takahashi, Bonnie C Sohn, Brandon P Verdoorn, et al.
Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Systematic Biology|July 14, 2023
Phylogenomics reveals patterns of ancient hybridization and differential diversification that contribute to phylogenetic conflict in willows, poplars, and close relativesBrian J Sanderson, Diksha Gambhir, Guanqiao Feng, et al.
BMC Ecology and Evolution|November 17, 2023
A phylogeny of the evening primrose family (Onagraceae) using a target enrichment approach with 303 nuclear lociRick P Overson, Matthew G Johnson, Lindsey L Bechen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2016
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort studySebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Frontiers in Immunology|October 12, 2023
The evolution of antimicrobial peptides in ChiropteraFrancisco X Castellanos, Diana Moreno-Santillán, Graham M Hughes, et al.
Systematic Biology|May 18, 2022
Target Enrichment and Extensive Population Sampling Help Untangle the Recent, Rapid Radiation of Oenothera Sect. CalylophusBenjamin J Cooper, Michael J Moore, Norman A Douglas, et al.
Infection|January 17, 2023
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trialMatthew G Johnson, Julie M Strizki, Michelle L Brown, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|February 21, 2007
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trialGunjan Y Gandhi, Gregory A Nuttall, Martin D Abel, et al.
Journal of Primary Care & Community Health|April 3, 2026
Health Care Use and Outcomes Among Participants Enrolled in the Mayo Clinic Primary Care House Call Program: A Case-Control StudyPaul Y Takahashi, Bonnie C Sohn, Brandon P Verdoorn, et al.
Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Systematic Biology|July 14, 2023
Phylogenomics reveals patterns of ancient hybridization and differential diversification that contribute to phylogenetic conflict in willows, poplars, and close relativesBrian J Sanderson, Diksha Gambhir, Guanqiao Feng, et al.
BMC Ecology and Evolution|November 17, 2023
A phylogeny of the evening primrose family (Onagraceae) using a target enrichment approach with 303 nuclear lociRick P Overson, Matthew G Johnson, Lindsey L Bechen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.
The Journal of Antimicrobial Chemotherapy|July 14, 2016
Short-term risk of liver and renal injury in hospitalized patients using micafungin: a multicentre cohort studySebastian Schneeweiss, Peggy L Carver, Kausik Datta, et al.
Frontiers in Immunology|October 12, 2023
The evolution of antimicrobial peptides in ChiropteraFrancisco X Castellanos, Diana Moreno-Santillán, Graham M Hughes, et al.
Systematic Biology|May 18, 2022
Target Enrichment and Extensive Population Sampling Help Untangle the Recent, Rapid Radiation of Oenothera Sect. CalylophusBenjamin J Cooper, Michael J Moore, Norman A Douglas, et al.
Infection|January 17, 2023
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trialMatthew G Johnson, Julie M Strizki, Michelle L Brown, et al.
Pageof 11